In: Accounting
On January 1, 2017, Fisher Corporation purchased 40 percent (86,000 shares) of the common stock of Bowden, Inc. for $974,000 in cash and began to use the equity method for the investment. The price paid represented a $60,000 payment in excess of the book value of Fisher's share of Bowden's underlying net assets. Fisher was willing to make this extra payment because of a recently developed patent held by Bowden with a 15-year remaining life. All other assets were considered appropriately valued on Bowden's books.
Bowden declares and pays a $108,000 cash dividend to its stockholders each year on September 15. Bowden reported net income of $380,000 in 2017 and $340,000 in 2018. Each income figure was earned evenly throughout its respective year.
On July 1, 2018, Fisher sold 10 percent (21,500 shares) of Bowden's outstanding shares for $338,000 in cash. Although it sold this interest, Fisher maintained the ability to significantly influence Bowden's decision-making process.
Prepare the journal entries for Fisher for the years of 2017 and 2018. (If no entry is required for a transaction/event, select "No journal entry required" in the first account field. Do not round intermediate calculations. Round your final answers to the nearest whole dollar.)
1.Record cost of 86,000 shares of Bowden Company.
2. Record the annual dividend declared and received from Bowden.
3. Record accrue 2017 income based on 40% ownership of Bowden.
4. Record amortization of $60,000 excess patent fair value [indicated in problem] over 15 years.
5. Record the entry to accrue ½ year income of 40% ownership.
6. Record ½ year amortization of patent to establish correct book value for investment as of 7/1/18.
7. Record 21,500 shares of Bowden Company sold; investment basis computed below.
8. Record annual dividend declared and received.
9. Record ½ year income based on remaining 30% ownership.
10.Record ½ year of patent amortization.
accounts
Particulars | Debit | Credit | |
---|---|---|---|
1. | Investment in Bowden a/c | $974000 | |
To Cash | $974000 | ||
(Being amount paid to acquire sh) | |||
2.a | Dividend Receivable a/c | $34200 | |
To Investment in Bowden a/c | $34200 | ||
(Annual dividend received as of Sep 15 2017) | |||
3. | Acrrued Income a/c (380000 x 40%) | $152000 | |
To Income a/c | $152000 | ||
(Accrued Income received for year 2017) | |||
4. | Patient a/c | $60000 | |
To Cash | $60000 | ||
(Purchase of patent for $60000) | |||
Amortization Expenses | $4000 | ||
To Patent | $4000 | ||
(Annual amortization expenses over 15 yrs of useful life) |
|||
5.b | Accrued Income a/c | $220000 | |
To Income a/c | $220000 | ||
(Accrued income received over 1 and half yr) | |||
6. | Amortization Expenses | $2000 | |
To Patent | $2000 | ||
(Half yearly amortization expense value) | |||
7. | Cash a/c | $338000 | |
To Sales | $338000 | ||
(Cash sales of 21500 outstanding shares) | |||
8. | Dividend receivable a/c | $43200 | |
To Investment in Bowden a/c | $43200 | ||
(Annual dividend received) | |||
9.c | Accrued Income a/c | $51000 | |
To Income a/c | $51000 | ||
(Half yearly income received based on 30% ownership for year 2018) |
|||
10. | Amortization Expenses | $2000 | |
To Patient | $2000 | ||
(Half yearly amortization expense value) | |||
Workings
2.a 108000 x 40 % = 43200
For 9 months -- 43200 / 12 x 9 = 32400
For rest 15 days -- 43200 / 12 / 2 = 1800
Ie -- as of September 15 2017 dividend will be = 32400 + 1800 = 34200
5.b 340000 / 2 = 170000
380000 + 170000 = 550000
550000 x 40 % = 220000
9.c Haly yearly income based on remaining 30 % ownership
340000 x 6 / 12 = 170000
170000 x 30 % = 51000